Characteristics of the 22 Patients
| Characteristic | Value |
|---|---|
| Male patients (n) | 7 |
| Age (y) | |
| Median | 32.5 |
| Range | 20–69 |
| Disease duration (mo) | |
| Median | 60 |
| Range | 5–384 |
| Disease location | |
| Colonic | 11 |
| Ileal | 2 |
| Ileocolonic | 9 |
| Treatment | |
| Mesalazine | 5 |
| Antibiotics | 1 |
| Steroids | 6 |
| Immunosuppressors | 10 |
| Anti–tumor necrosis factor | 8 |
| CDAI | |
| Median | 178 |
| Range | 54–331 |
| CDEIS | |
| Median | 6.5 |
| Range | 0–28 |
| CRP (mg/L) | |
| Median | 17.4 |
| Range | 1.1–78.1 |
| Fecal calprotectin (μg/mL) | |
| Median | 535 |
| Range | 8.4–1,250 |